Tag: Gene therapy company

Lilly wraps up acquisition of gene therapy company Prevail Therapeutics

pharmanewsdaily- January 23, 2021

Eli Lilly and Company (Lilly) has completed its previously announced deal worth up to $1.04 billion of US gene therapy company Prevail Therapeutics. The US ... Read More

Lilly to acquire US gene therapy company Prevail Therapeutics in $1bn deal

pharmanewsdaily- December 16, 2020

Eli Lilly and Company (Lilly) has signed a deal worth up to $1.04 billion to acquire Prevail Therapeutics, a US gene therapy company engaged in ... Read More

HMR59 : Janssen acquires rights to geographic atrophy treatment candidate from Hemera

pharmanewsdaily- December 3, 2020

Geographic atrophy treatment : Janssen Pharmaceuticals has signed a licensing deal to acquire rights to HMR59, an investigational gene therapy for geographic atrophy, from clinical ... Read More

Gene therapy company 4D Molecular Therapeutics raises $70m in Series C round

pharmanewsdaily- June 17, 2020

California-based gene therapy company 4D Molecular Therapeutics (4DMT), which is focused on adeno-associated virus (AAV) gene therapy vector discovery and product development, has raised $70 ... Read More

Roche signs $2.85bn deal with Sarepta for SRP-9001 DND gene therapy

pharmanewsdaily- December 24, 2019

Roche has signed a licensing deal worth up to $2.85 billion with Sarepta Therapeutics for the exclusive ex-US commercial rights to the latter’s SRP-9001 (AAVrh74.MHCK7.micro-dystrophin), ... Read More

Astellas Pharma to acquire US gene therapy company Audentes Therapeutics

pharmanewsdaily- December 8, 2019

Astellas acquisition of Audentes: Japanese pharma company Astellas Pharma has agreed to acquire US gene therapy company Audentes Therapeutics in an all-cash deal worth about ... Read More

Ferring, Blackstone invest $570m in nadofaragene firadenovec gene therapy

pharmanewsdaily- November 26, 2019

Ferring Pharmaceuticals, a Swiss specialty biopharmaceutical group, has teamed up with private investment platform Blackstone Life Sciences to jointly invest more than $570 million in ... Read More

Cellectis begins MELANI-01 clinical trial for UCARTCS1 in multiple myeloma

pharmanewsdaily- October 30, 2019

Cellectis said that it has dosed the first patient in a phase 1  study - the MELANI-01 clinical trial to evaluate UCARTCS1, an allogeneic off-the-shelf ... Read More

Avrobio gets FDA orphan status for AVR-RD-02 in Gaucher disease

pharmanewsdaily- October 25, 2019

US gene therapy company Avrobio has secured orphan-drug designation for AVR-RD-02, its investigational gene therapy, for the treatment of Gaucher disease, from the US Food ... Read More

Gene therapy company 4D Molecular Therapeutics raises $90m in new funding

pharmanewsdaily- September 6, 2018

California-based gene therapy company 4D Molecular Therapeutics (4DMT), which is focused on adeno-associated virus (AAV) gene therapy vector discovery and product development, has raised $90 ... Read More